Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Molecular Tumor Board, Biomarker Report Interpretation

Debyani Chakravarty

PhD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Director, Clinical Bioinformatics

42
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Debyani Chakravarty directs clinical bioinformatics at MSKCC and is a principal developer of OncoKB, the widely used precision oncology knowledge base that curates clinical significance of cancer gene alterations. OncoKB is a foundational resource for molecular tumor boards, providing evidence-based tier classifications for thousands of mutations. Her work on standardizing biomarker report interpretation has improved consistency in molecular tumor board recommendations.

Share:

🧪Research Fields 研究领域

oncokb actionable mutations database
genomic report interpretation
biomarker annotation clinical
actionability evidence curation
molecular tumor board informatics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Debyani Chakravarty 的研究动态

Follow Debyani Chakravarty's research updates

留下邮箱,当我们发布与 Debyani Chakravarty(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment